aMY bILLET

Amy Billett, MD

Associate in Medicine; Director of Safety and Quality, Division of Hematology/Oncology

Associate Professor of Pediatrics, Harvard Medical School

    Contact: 617-632-5640
  • Fax: 617-632-5710

Medical Services

Specialties

  • Hematologic Malignancy
  • Electronic Health Records
  • Quality Improvement
  • Patient Safety

Departments

  • Hematology / Oncology
  • Medicine
To schedule an appointment: Call 617-632-5640

Experience and Education

Education

Medical School

Harvard Medical School, 1984

Boston, MA

Internship

Children's Hospital and Medical Center, 07/84 to 06/85

Seattle, WA

Residency

University of Washington Hospitals, 07/85 to 06/87

Seattle, WA

Fellowship, Pediatric Hematology/Oncology

Boston Children's Hospital//Dana-Farber Cancer Institute, 7/87 to 6/90

Boston , MA

Certifications

  • Pediatric Hematology/Oncology

Publications

Publications powered by Harvard Catalyst Profiles
  1. Hord JD, Lawlor J, Werner E, Billett AL, Bundy DG, Winkle C, Gaur AH. Central Line Associated Blood Stream Infections in Pediatric Hematology/Oncology Patients With Different Types of Central Lines. Pediatr Blood Cancer. 2016 Sep; 63(9):1603-7.
  2. Green AL, Yi J, Bezler N, Pikman Y, Tubman VN, Obeng EA, O'Neil T, Mersereau R, Morrissey L, Billett AL. A Prospective Cohort Quality Improvement Study to Reduce the Time to Antibiotics for New Fever in Neutropenic Pediatric Oncology Inpatients. Pediatr Blood Cancer. 2016 Jan; 63(1):112-7.
  3. Bundy DG, Gaur AH, Billett AL, He B, Colantuoni EA, Miller MR. Preventing CLABSIs among pediatric hematology/oncology inpatients: national collaborative results. Pediatrics. 2014 Dec; 134(6):e1678-85.
  4. Billett AL. Avoiding risky business: supporting optimal home medication administration for children with cancer. J Oncol Pract. 2014 Nov; 10(6):377-9.
  5. Zenlea IS, Billett A, Hazen M, Herrick DB, Nakamura MM, Jenkins KJ, Woolf AD, Kesselheim JC. Trainee and program director perceptions of quality improvement and patient safety education: preparing for the next accreditation system. Clin Pediatr (Phila). 2014 Nov; 53(13):1248-54.
  6. Croteau SE, Henderson ER, Billett AL, Gebhardt MC, Voss SD. Resolving bony abnormality evolves to diffuse large B-cell lymphoma. Pediatr Blood Cancer. 2013 Oct; 60(10):E113-5.
  7. Billett AL, Colletti RB, Mandel KE, Miller M, Muething SE, Sharek PJ, Lannon CM. Exemplar pediatric collaborative improvement networks: achieving results. Pediatrics. 2013 Jun; 131 Suppl 4:S196-203.
  8. Friedmann AM, Wolfson JA, Hudson MM, Weinstein HJ, Link MP, Billett A, Larsen EC, Yock T, Donaldson SS, Marcus K, Krasin MJ, Howard SC, Metzger ML. Relapse after treatment of pediatric Hodgkin lymphoma: outcome and role of surveillance after end of therapy. Pediatr Blood Cancer. 2013 Sep; 60(9):1458-63.
  9. Walsh KE, Roblin DW, Weingart SN, Houlahan KE, Degar B, Billett A, Keuker C, Biggins C, Li J, Wasilewski K, Mazor KM. Medication errors in the home: a multisite study of children with cancer. Pediatrics. 2013 May; 131(5):e1405-14.
  10. Kelly MS, Conway M, Wirth KE, Potter-Bynoe G, Billett AL, Sandora TJ. Microbiology and risk factors for central line-associated bloodstream infections among pediatric oncology outpatients: a single institution experience of 41 cases. J Pediatr Hematol Oncol. 2013 Mar; 35(2):e71-6.
  11. Show all
  12. Gaur AH, Bundy DG, Gao C, Werner EJ, Billett AL, Hord JD, Siegel JD, Dickens D, Winkle C, Miller MR. Surveillance of hospital-acquired central line-associated bloodstream infections in pediatric hematology-oncology patients: lessons learned, challenges ahead. Infect Control Hosp Epidemiol. 2013 Mar; 34(3):316-20.
  13. Metzger ML, Billett A, Link MP. The impact of drug shortages on children with cancer--the example of mechlorethamine. N Engl J Med. 2012 Dec 27; 367(26):2461-3.
  14. Metzger ML, Weinstein HJ, Hudson MM, Billett AL, Larsen EC, Friedmann A, Howard SC, Donaldson SS, Krasin MJ, Kun LE, Marcus KJ, Yock TI, Tarbell N, Billups CA, Wu J, Link MP. Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma. JAMA. 2012 Jun 27; 307(24):2609-16.
  15. Billett AL, Reaman GH. What price cure? Pediatr Blood Cancer. 2011 Dec 1; 57(6):908-9.
  16. Kelly M, Conway M, Wirth K, Potter-Bynoe G, Billett AL, Sandora TJ. Moving CLABSI prevention beyond the intensive care unit: risk factors in pediatric oncology patients. Infect Control Hosp Epidemiol. 2011 Nov; 32(11):1079-85.
  17. Ashworth LA, Billett A, Mitchell P, Nuti F, Siegel C, Bousvaros A. Lymphoma risk in children and young adults with inflammatory bowel disease: analysis of a large single-center cohort. Inflamm Bowel Dis. 2012 May; 18(5):838-43.
  18. Feusner JH, Ritchey AK, Cohn SL, Billett AL. Management of tumor lysis syndrome: need for evidence-based guidelines. J Clin Oncol. 2008 Dec 1; 26(34):5657-8; author reply 5658-9.
  19. Donaldson SS, Link MP, Weinstein HJ, Rai SN, Brain S, Billett AL, Hurwitz CA, Krasin M, Kun LE, Marcus KC, Tarbell NJ, Young JA, Hudson MM. Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease. J Clin Oncol. 2007 Jan 20; 25(3):332-7.
  20. Donaldson SS, Link MP, Weinstein HJ, Rai, SN, Brain S, Billett AL, Hurwitz CA, Krasin M, Kun LE, Marcus KJ, Tarbell NJ, Young JA, Hudson MM. Final Results of a Prospective Clinical Trial with VAMP and Low-Dose Involved-Field Radiation for Children with Low-Risk Hodgkin’s Disease. JCO. 2007; 25(3):332-7.
  21. Barredo JC, Devidas M, Lauer SJ, Billett A, Marymont M, Pullen J, Camitta B, Winick N, Carroll W, Ritchey AK. Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study. J Clin Oncol. 2006 Jul 1; 24(19):3142-9.
  22. Sandler ES, Homans A, Mandell L, Amylon M, Wall DA, Devidas M, Buchanan GR, Lipton JM, Billett AL. Hematopoietic stem cell transplantation after first marrow relapse of non-T, non-B acute lymphoblastic leukemia: a pediatric oncology group pilot feasibility study. J Pediatr Hematol Oncol. 2006 Apr; 28(4):210-5.
  23. Eapen M, Raetz E, Zhang MJ, Muehlenbein C, Devidas M, Abshire T, Billett A, Homans A, Camitta B, Carroll WL, Davies SM. Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. Blood. 2006 Jun 15; 107(12):4961-7.
  24. Mueller B, Billett AL. Regulating Patient Safety in Cancer Treatment. Pizzo PA & Poplak DF, eds. Principles and Practice of Pediatric Oncology. 2006; 525-537.
  25. Berde C, Collins JJ, Billett AL. Symptom management in supportive care. Pizzo PA & Poplack DC, eds. Principles and Practice of Pediatric Oncology. 2006; 1348-1379.
  26. Berg SL, Blaney SM, Devidas M, Lampkin TA, Murgo A, Bernstein M, Billett A, Kurtzberg J, Reaman G, Gaynon P, Whitlock J, Krailo M, Harris MB. Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group. J Clin Oncol. 2005 May 20; 23(15):3376-82.
  27. Marcus KJ, Goumnerova L, Billett AL, Lavally B, Scott RM, Bishop K, Xu R, Young Poussaint T, Kieran M, Kooy H, Pomeroy SL, Tarbell NJ. Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial. Int J Radiat Oncol Biol Phys. 2005 Feb 1; 61(2):374-9.
  28. Dinning C, Branowicki P, O'Neill JB, Marino BL, Billett A. Chemotherapy error reduction: a multidisciplinary approach to create templated order sets. J Pediatr Oncol Nurs. 2005 Jan-Feb; 22(1):20-30.
  29. Donaldson SS, Tarbell NJ, Weinstein HJ, Link MP, L Kun, Billett AL, Marcus KC, Hurwitz CA, Young JA, Brain S, Hudson MM. End Results of a Prospective Clinical Trial with VAMP and Low-dose, Involved-Field Radiation for Pediatric Patients with Favorable, Early-Stage Hodgkin’s Disease. American Society for Therapeutic Radiation and Oncology. 2005.
  30. Hudson MM, Krasin M, Link MP, Donaldson SS, Billups C, Merchant TE, Kun L, Billett AL, Kaste S, Tarbell NJ, Howard S, Friedmann AM, Hurwitz CA, Young JA, Marcus KJ, Rai S, Cowan T, Weinstein HJ. Risk-adapted combined modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease. J Clin Oncol. 2004; 22(22):4541-4550.
  31. Carpentieri SC, Waber DP, Pomeroy SL, Scott RM, Goumnerova LC, Kieran MW, Billett AL, Tarbell NJ. Neuropsychological functioning after surgery in children treated for brain tumor. Neurosurgery. 2003 Jun; 52(6):1348-56; discussion 1356-7.
  32. Smith RS, Chen Q, Hudson MM, Link MP, Kun L, Weinstein H, Billett A, Marcus KJ, Tarbell NJ, Donaldson SS. Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy. J Clin Oncol. 2003 May 15; 21(10):2026-33.
  33. Branowicki P, O'Neill JB, Dwyer JL, Marino BL, Houlahan K, Billett A. Improving complex medication systems: an interdisciplinary approach. J Nurs Adm. 2003 Apr; 33(4):199-200.
  34. Marcus KJ, Dutton SC, Barnes P, Coleman CN, Pomeroy SL, Goumnerova L, Billett AL, Kieran M, Tarbell NJ. A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma. Int J Radiat Oncol Biol Phys. 2003 Apr 1; 55(5):1182-5.
  35. Donaldson SS, Hudson MM, Lamborn KR, Link MP, Kun L, Billett AL, Marcus KC, Hurwitz CA, Young JA, Tarbell NJ, Weinstein HJ. VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: results of a prospective clinical trial. J Clin Oncol. 2002 Jul 15; 20(14):3081-7.
  36. Marino BL, Branowicki P, Bennett JA, Houlahan K, O'Neill JB, Dwyer JL, Billett A. Evaluating process changes in a pediatric hospital medication system. Outcomes Manag. 2002 Jan-Mar; 6(1):10-5; quiz 16.
  37. LeClerc JM, Billett AL, Gelber RD, Dalton V, Tarbell N, Lipton JM, Barr R, Clavell LA, Asselin B, Hurwitz C, Schorin M, Lipshultz SE, Declerck L, Silverman LB, Cohen HJ, Sallan SE. Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber ALL Consortium Protocol 87-01. J Clin Oncol. 2002 Jan 1; 20(1):237-46.
  38. Berde C, Collins JJ, Billett AL. Symptom management in supportive care. Pizzo PA & Poplack DC, eds. Principles and Practice of Pediatric Oncology. 2002; 1301-1332.
  39. Carpentieri SC, Waber DP, Scott RM, Goumnerova LC, Kieran MW, Cohen LE, Kim F, Billett AL, Tarbell NJ, Pomeroy SL. Memory deficits among children with craniopharyngiomas. Neurosurgery. 2001 Nov; 49(5):1053-7; discussion 1057-8.
  40. Carpentieri SC, Waber DP, Scott RM, Goumnerova LC, Kieran MW, Cohen LE, Kim F, Billett AL, Tarbell NJ, Pomeroy SL. Memory deficits in children with craniopharyngioma. Neurosurgery. 2001; 49(5):1-6.
  41. Kieran MW, Billett A. Antiangiogenesis therapy. Current and future agents. Hematol Oncol Clin North Am. 2001 Oct; 15(5):835-51, viii.
  42. Tzika AA, Zurakowski D, Poussaint TY, Goumnerova L, Astrakas LG, Barnes PD, Anthony DC, Billett AL, Tarbell NJ, Scott RM, Black PM. Proton magnetic spectroscopic imaging of the child's brain: the response of tumors to treatment. Neuroradiology. 2001 Feb; 43(2):169-77.
  43. Abshire TC, Pollock BH, Billett AL, Bradley P, Buchanan GR. Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a Pediatric Oncology Group Study. Blood. 2000 Sep 1; 96(5):1709-15.
  44. Silverman LB, Billett AL. High dose therapy in acute lymphoblastic leukemia. Armitage JA and Antman KH, eds. High Dose Cancer Therapy: Pharmacology, Hematopoietins and Stem Cells. 2000; 691-703.
  45. Billett AL, Dinning C, Marino B, Lucich J, and Branowicki P. Chemotherapy order templates created by a multidisciplinary team reduced changes in signed chemotherapy orders. Journal of Pediatric Hematology/Oncology. 2000; 22(649):384.
  46. Kim JYH, Sutton ME, Lu DJ, Cho TA, Goumnerova LC, Goritchenko L, Kaufman JR, Lam KK, Billett AL, et al. Activation of neutrophin-3 receptor TrkC induces apoptosis in medulloblastomas. Cancer Research. 1999; 59(3):711-719.
  47. Billett AL, Ritz J. Autologous hematopoietic cell transplantation for acute lymphoblastic leukemia. Thomas ED, Blume KG, and Forman SJ, eds. Hematopoietic Cell Transplantation. 1999; 978-989.
  48. Silverman LB, Billett AL, Sallan SE. Treatment of acute leukemia in children. Gellis & Kagan’s Current Pediatric Therapy. 1999; 717-721.
  49. Abdalla HI, Billett A, Kan AK, Baig S, Wren M, Korea L, Studd JW. Obstetric outcome in 232 ovum donation pregnancies. Br J Obstet Gynaecol. 1998 Mar; 105(3):332-7.
  50. Homans A, Kurtzberg J, Pollock B, DeOliveira D, Billett A. Comparison of polyethylene glycol conjugated (PEG) L-Asparaginase (ASP) with native E.coli ASP for induction therapy of relapsed childhood acute lymphoblastic leukemia (ALL): A Pediatric Oncology Group study. Proc Am Soc Clin Oncol. 1998; 17(851):221a.
  51. Duerst RE, Liesveld J, Rapaport A, Abboud C, Billett AL. Autologous stem cell rescue for high-risk central nervous system tumors: phase I study of cyclophosphamide, carboplatin and melphalan. American Society of Blood and Marrow Transplantation, Miami Beach, FL. 1998.
  52. Lehmann LE, Tarbell NJ, Renella R, Sallan SE, Weinstein HJ, Billett AL. Excellent outcome for pediatric patients with mediastinal lymphoblastic lymphoma when treated with intensive acute lymphoblastic leukemia therapy. Am Soc Hem. 1998; 92(10 (Suppl 1 No. 1)):620a.
  53. Dutton SC, Billett AL, Kieran MW, Barnes P, Black PM, Goumnerova LC, Scott RM, LaVally B, Leong T, Pomeroy S, Tarbell NJ. Fractionated stereotactic radiation therapy for craniopharyngioma: Preliminary results of a prospective study. 8th International Symposium on Pediatric Neuro-Oncology. Rome. 1998.
  54. Billett AL, Gelber RD, Tarbell NJ, Dalton V, Donnelly M, Sallan SE. Results of Dana-Farber Cancer Institute consortium childhood acute lymphoblastic leukemia protocols. Int J Ped Hem Onc. 1998; 5(2-4):115-123.
  55. Weisdorf DJ, Billett AL, Hannan P, Ritz J, Sallan SE, Steinbuch M, Ramsay NK. Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia. Blood. 1997 Oct 15; 90(8):2962-8.
  56. Hardenbergh PH, Golden J, Billett AL, Scott RM, Shrieve DC, Silver B, Loeffler JS, Tarbell NJ. Intracranial germinoma: the case for lower dose radiation therapy. Int J Radiat Oncol Biol Phys. 1997; 39(2):419-426.
  57. McLendon RE, Bentley RC, Parisi JE, Tien RD, Harrison JC, Tarbell NJ, Billett AL, Gualtieri RJ, Friedman HS. Malignant supratenorial glial-neuronal neoplasms: report of two cases and review of the literature. Arch Pathol Lab Med. 1997; 121(5):485-492.
  58. Billett AL, Pollock BH, Abshire TC, Buchanan GR. Outcome of children with B-lineage acute lymphoblastic leukemia (ALL) in first bone marrow relapse. Blood. 1997; 90 (Suppl 1):332a.
  59. Farah RA, Billett AL, Pollock BH, Buchanan GR, Schneider NR. Significance of cytogenetic findings in childhood acute lymphoblastic leukemia (ALL) at first marrow relapse. A Pediatric Oncology Group study. Blood. 1997; 90 (Suppl 1):185a.
  60. Billett AL and Sallan SE. Management of nausea and vomiting. Pizzo PA & Poplack DC, eds. Principles and Practice of Pediatric Oncology. 1997; 1201-1208.
  61. Bakardjiev AI, Barnes PD, Goumnerova LC, Black PM, Scott RM, Pomeroy SL, Billett A, Loeffler JS, Tarbell NJ. Magnetic resonance imaging changes after stereotactic radiation therapy for childhood low grade astrocytoma. Cancer. 1996 Aug 15; 78(4):864-73.
  62. Cardoso AA, Schultze JL, Boussiotis VA, Freeman GL, Seamon MJ, Laszlo S, Billett AL, Sallan SE, Gribben JG, Nadler LM. Pre-B acute lymphoblastic leukemia cell may introduce T-cell anergy to alloantigen. Blood. 1996; 88(8):41-48.
  63. Parsons SK, Castellino SM, Lehmann LE, Eickhoff CE, Tarbell NJ, Sallan SE, Weinstein HJ, Billett AL. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children. Bone Marrow Transplant. 1996 May; 17(5):763-8.
  64. Tarbell NJ, Scott RM, Goumnerova LC, Pomeroy SL, Black PM, Barnes P, Billett AL, LaVally B, Shrieve D, Helmus A, Kooy HM, Loeffler JS. Craniopharyngioma: Preliminary results of stereotactic radiation therapy. Radiosurgery. 1996; 1995:75-82.
  65. Billett AL, Soiffer RJ, Eickhoff C, Donnelly M, Tarbell NJ, Weinstein HJ, Sallan SE, Ritz J. Monoclonal antibody-purged autologous bone marrow transplantation for acute lymphoblastic leukemia in children and adults at high risk of relapse: The Dana-Farber Cancer Institute experience. In Dicky KA, ed. Autologous Bone Marrow Transplantation: Proceedings of the Seventh International Symposium. 1995; 7:145-156.
  66. Laufer MR, Billett AL, Diller LR, Chin LM, Tarbell NJ. A new technique for laparoscopic prophylactic oophoropexy before cranial irradiation in children with medulloblastoma. Adolescent and Pediatric Gynecology. 1995; 8:77-81.
  67. Billett AL, Sallan SE. Antiemetics in children receiving cancer chemotherapy. Support Care Cancer. 1994 Sep; 2(5):279-85.
  68. Tarbell NJ, Barnes P, Scott RM, Goumnerova L, Pomeroy SL, Black PM, Sallan SE, Billett A, LaVally B, Helmus A, et al. Advances in radiation therapy for craniopharyngiomas. Pediatr Neurosurg. 1994; 21 Suppl 1:101-7.
  69. Billett AL and Sallan SE. Acute lymphoblastic leukemia. Cassidy JR, ed. Pediatric Radiation Oncology. 1994; 87-97.
  70. Dutton S, Billett AL, Sallan S, Barnes P, Goumnerova L, Pomeroy S, Leong T, Loeffler J, Tarbell N. Medulloblastoma: Prognostic significance of postoperative tumor and response to chemotherapy. Proc Am Soc Clin Oncol. 1994; 13(514):181.
  71. Billett AL, Abshire TC, Pollock BH, Buchanan GR. Second remission and early outcome for children with B-lineage acute lymphoblastic leukemia in first bone marrow relapse. Blood. 1994; 84 (Suppl 1):148a.
  72. Skapek S, Goumnerova L, Leong T, LaVally B, Helmus A, Billett AL, Sallan S, Tarbell N. . Clinical outcome in children with central nervous system primitive neuroectodermal tumor (CNS PNET) outside of the posterior fossa (PF). Proc Am Soc Clin Oncol. 1994; 13(497):177.
  73. Tarbell NJ, Barnes P, Scott RM, Goumnerova L, Pomeroy S, Black PM, Sallan SE, Billett AL, LaVally B, Helmus A, Kooy HM, Loeffler. Advances in radiation therapy for craniopharyngioma. Ped Neurosurg. 1994; 21 (suppl 1):101-107.
  74. Billett AL, Sallan SE. Autologous bone marrow transplantation in childhood acute lymphoid leukemia with use of purging. Am J Pediatr Hematol Oncol. 1993 May; 15(2):162-8.
  75. Billett AL, Kornmehl E, Tarbell NJ, Weinstein HJ, Gelber RD, Ritz J, Sallan SE. Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia. Blood. 1993 Mar 15; 81(6):1651-7.
  76. Billett AL and Sallan SE. Autologous bone transplantation in childhood acute lymphoblastic leukemia with use of purging. AM J Ped Hem Onc. 1993.
  77. Billett AL and Sallan SE. Management of nausea and vomiting. In Pizzo PA and Poplack DG, eds. Principles and Practices of Pediatric Oncology. 1993; 1051-1057.
  78. Billett AL and Sallan SE. Treatment of acute leukemia in children. In Burg FD, Ingelfinger JR, and Wald ER, eds. Current Pediatric Therapy. 1993; 267-270.
  79. Billett AL, Carls A, Gelber RD, Sallan SE. Allergic reactions to Erwinia asparaginase in children with acute lymphoblastic leukemia who had previous allergic reactions to Escherichia coli asparaginase. Cancer. 1992 Jul 1; 70(1):201-6.
  80. Billett AL. High dose therapy in acute lymphoblastic leukemia. Armitage JA and Antman KH, eds. High dose cancer therapy. Pharmacology, hematopoietins and stem cells. 1992; 607-618.
  81. Billett AL, Tarbell N, Donnelly M, Gelber R, Weinstein H, Ritz J, Sallan S. Autologous bone marrow transplantation for relapsed childhood acute lymphoblastic leukemia after a short first remission. Blood. 1992; 80 (Suppl 1):24a.
  82. Billett AL and Sallan SE. Acute leukemia in childhood. In: Brian MC, and Carbone PP, eds. Current therapy in hematology-oncology-4. 1992; 67-73.
  83. Soiffer RJ, Billett AL, Roy DC, Dalton V, Sallan SE, Ritz J. Autologous bone marrow transplantation for acute lymphoblastic leukemia in second or subsequent complete remission: Ten years experience at the Dana-Farber Cancer Institute. In Dicky KA, Armitage JO & Dicky MJ eds. Autologous Bone Marrow Transplantation: Proceedings of the Fifth International Symposium. Ebinger. 1991; 167-176.
  84. Garber JE, Burke EM, Lavally BL, Billett AL, Sallan SE, Scott RM, Kupsky W, Li FP. Choroid plexus tumors in the breast cancer-sarcoma syndrome. Cancer. 1990 Dec 15; 66(12):2658-60.
  85. Sallan SE, Niemeyer CM, Billett AL, Lipton JM, Tarbell NJ, Gelber RD, Murray C, Pittinger TP, Wolfe LC, Bast RC, et al. Autologous bone marrow transplantation for acute lymphoblastic leukemia. J Clin Oncol. 1989 Nov; 7(11):1594-601.
  86. Billett AL, Baas F, Raponi R, Croop JM, Arceci RJ. mdr1 and mdr3 expression in patients with leukemia. Blood. 1988; 74:346a.
  87. Jones GP, Hooper PT, Rivett DE, Tucker DJ, Lambert G, Billett A. Nephrotoxic activity in rats fed diets containing DL-3-(N-phenylethylamino)-alanine. Aust J Biol Sci. 1987; 40(2):115-23.
  88. Polaner DM, Billett AL, Richardson MA. Cardiovocal syndrome. Pediatrics. 1986; 78(2):380.
  89. Tao ML, Barnes PD, Billett AL, Leong T, Shrieve DC, Scott RM, Tarbell NJ. Childhood optic chiasm gliomas: radiographic response following radiotherapy and long-term clinical outcome. Int J Radiat Oncol Biol Phys. 1997 Oct 1; 39(3):579-87.
  90. Zhou M, Gu L, Abshire TC, Homans A, Billett AL, Yeager AM, Findley HW. Incidence and prognostic significance of MDM2 oncoprotein overexpression in relapsed childhood acute lymphoblastic leukemia. Leukemia. 2000 Jan; 14(1):61-7.
  91. Lowry RJ, Billett A, Buchanan C, Whiston S. Increasing breastfeeding and reducing smoking in pregnancy: a social marketing success improving life chances for children. Perspect Public Health. 2009 Nov; 129(6):277-80.
  92. Kelly ME, Lu X, Devidas M, Camitta B, Abshire T, Bernstein ML, Billett A, Homans A, Sandler E, Buchanan G. Treatment of relapsed precursor-B acute lymphoblastic leukemia with intensive chemotherapy: POG (Pediatric Oncology Group) study 9411 (SIMAL 9). J Pediatr Hematol Oncol. 2013 Oct; 35(7):509-13.
  93. Neuss MN, Gilmore TR, Belderson KM, Billett AL, Conti-Kalchik T, Harvey BE, Hendricks C, LeFebvre KB, Mangu PB, McNiff K, Olsen M, Schulmeister L, Von Gehr A, Polovich M. 2016 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology. J Oncol Pract. 2016 Nov 21; JOP2016017905.
To schedule an appointment: Call 617-632-5640

Locations

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close